Sunday, August 14, 2022 | Back issues
Courthouse News Service Courthouse News Service

Pharma IPO Class Action

ProNAi Therapeutics raised $144 million in its IPO at $17 a share, then the price dropped to $1.53 when its cancer drug failed, shareholders say in a class action in San Mateo County Court.

REDWOOD CITY, Calif. – ProNAi Therapeutics raised $144 million in its IPO at $17 a share, then the price dropped to $1.53 when its cancer drug failed, shareholders say in a class action in San Mateo County Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...